Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power. Our products help address some of today's biggest challenges, including global population growth, an aging society and the need to make efficient - and, wherever possible, sustainable - use of natural resources. In line with our mission "Bayer: Science For A Better Life," we aim to improve people's quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.
19
Total Investments
18
Portfolio Companies
-
Exits
6
Industries
General Information
Industries
Agriculture, Biotechnology +4
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Bayer
Recent Investments (19)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed | •••••• | Mar 2026 | |
| Grant | •••••• | Nov 2023 | |
| Series A | •••••• | Dec 2021 | |
| Series A | •••••• | Oct 2021 | |
| Acquisition | •••••• | Aug 2021 | |
|
|
Venture Round | •••••• | Mar 2021 |
|
|
Seed Round | •••••• | Nov 2020 |
|
|
Seed Round | •••••• | Nov 2019 |
|
|
Series B | •••••• | Nov 2019 |
|
|
Seed Round | •••••• | Oct 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.